Patents by Inventor Andrew Bryant
Andrew Bryant has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20220031952Abstract: The invention provides a syringe for use in an ophthalmic injection. The syringe comprises a body, a stopper and a plunger. The body comprises an outlet at an outlet end and the stopper is arranged within the body such that a front surface of the stopper and the body define a variable volume chamber from which a fluid can be expelled though the outlet. The plunger comprises a plunger contact surface at a first end and a rod extends between the plunger contact surface and a rear portion. The plunger contact surface is arranged to contact the stopper but not couple thereto, such that the plunger can be used to force the stopper towards the outlet end of the body, reducing the volume of the variable volume chamber, but not to move the stopper away from the outlet end.Type: ApplicationFiled: October 13, 2021Publication date: February 3, 2022Inventors: Andrew BRYANT, Heinrich BUETTGEN, Wolfgang PAPST, Marie PICCI
-
Patent number: 11185635Abstract: The invention provides a syringe for use in an ophthalmic injection. The syringe comprises a body, a stopper and a plunger. The body comprises an outlet at an outlet end and the stopper is arranged within the body such that a front surface of the stopper and the body define a variable volume chamber from which a fluid can be expelled though the outlet. The plunger comprises a plunger contact surface at a first end and a rod extends between the plunger contact surface and a rear portion. The plunger contact surface is arranged to contact the stopper but not couple thereto, such that the plunger can be used to force the stopper towards the outlet end of the body, reducing the volume of the variable volume chamber, but not to move the stopper away from the outlet end.Type: GrantFiled: June 1, 2021Date of Patent: November 30, 2021Assignee: NOVARTIS AGInventors: Andrew Bryant, Heinrich Buettgen, Wolfgang Papst, Marie Picci
-
Patent number: 11179521Abstract: The invention provides a syringe for use in an ophthalmic injection. The syringe comprises a body, a stopper and a plunger. The body comprises an outlet at an outlet end and the stopper is arranged within the body such that a front surface of the stopper and the body define a variable volume chamber from which a fluid can be expelled though the outlet. The plunger comprises a plunger contact surface at a first end and a rod extends between the plunger contact surface and a rear portion. The plunger contact surface is arranged to contact the stopper but not couple thereto, such that the plunger can be used to force the stopper towards the outlet end of the body, reducing the volume of the variable volume chamber, but not to move the stopper away from the outlet end.Type: GrantFiled: February 12, 2021Date of Patent: November 23, 2021Assignee: NOVARTIS AGInventors: Andrew Bryant, Heinrich Buettgen, Wolfgang Papst, Marie Picci
-
Patent number: 11147925Abstract: The invention provides a syringe for use in an ophthalmic injection. The syringe comprises a body, a stopper and a plunger. The body comprises an outlet at an outlet end and the stopper is arranged within the body such that a front surface of the stopper and the body define a variable volume chamber from which a fluid can be expelled though the outlet. The plunger comprises a plunger contact surface at a first end and a rod extends between the plunger contact surface and a rear portion. The plunger contact surface is arranged to contact the stopper but not couple thereto, such that the plunger can be used to force the stopper towards the outlet end of the body, reducing the volume of the variable volume chamber, but not to move the stopper away from the outlet end.Type: GrantFiled: February 14, 2020Date of Patent: October 19, 2021Assignee: NOVARTIS AGInventors: Andrew Bryant, Heinrich Buettgen, Wolfgang Papst, Marie Picci
-
Patent number: 11126909Abstract: A container arrangement (100) is disclosed, which is preferably destined for pharmaceutical products. The container arrangement includes a container body (110) and a first wireless communication systems (210) composed of a NFC system (210) including an NFC antenna (141). The container arrangement further includes a first and/or a second sensing-switching arrangement (143; 280) configured to include a preset status inhibiting a standardized operability of the first wireless communication system (210). The first sensing-switching arrangement (143) is configured to deregulate its preset status upon an initial opening event and the second sensing-switching arrangement (280) is configured to deregulate its preset status upon an unloading event.Type: GrantFiled: March 13, 2017Date of Patent: September 21, 2021Assignee: NOVARTIS AGInventor: Andrew Bryant
-
Publication number: 20210283336Abstract: The invention provides a syringe for use in an ophthalmic injection. The syringe comprises a body, a stopper and a plunger. The body comprises an outlet at an outlet end and the stopper is arranged within the body such that a front surface of the stopper and the body define a variable volume chamber from which a fluid can be expelled though the outlet. The plunger comprises a plunger contact surface at a first end and a rod extends between the plunger contact surface and a rear portion. The plunger contact surface is arranged to contact the stopper but not couple thereto, such that the plunger can be used to force the stopper towards the outlet end of the body, reducing the volume of the variable volume chamber, but not to move the stopper away from the outlet end.Type: ApplicationFiled: June 1, 2021Publication date: September 16, 2021Inventors: Andrew BRYANT, Heinrich BUETTGEN, Wolfgang PAPST, Marie PICCI
-
Publication number: 20210276641Abstract: A Mobile Climbing Robot (MCR) with wheel or endless-track type propulsion using magnetic attraction for generating adhering forces is adapted to climbing non-planar surfaces such as intersecting walls, pipes or other structural members. A tether is connected to the MCR through a tether linkage that causes the tether to bend with a radius that keeps it from protruding outside of the MCR wheels. The purpose of this is to increase the mobility when passing over variations of the climbing surface such as edges or corners. The purpose is to further protect the tether from wear caused by rubbing with the climbing surface.Type: ApplicationFiled: March 3, 2021Publication date: September 9, 2021Inventors: James Walter Beard, III, David Andrew Bryant, Stephen Lee Canfield
-
Patent number: 11110226Abstract: The invention provides a syringe for use in an ophthalmic injection. The syringe comprises a body, a stopper and a plunger. The body comprises an outlet at an outlet end and the stopper is arranged within the body such that a front surface of the stopper and the body define a variable volume chamber from which a fluid can be expelled though the outlet. The plunger comprises a plunger contact surface at a first end and a rod extends between the plunger contact surface and a rear portion. The plunger contact surface is arranged to contact the stopper but not couple thereto, such that the plunger can be used to force the stopper towards the outlet end of the body, reducing the volume of the variable volume chamber, but not to move the stopper away from the outlet end.Type: GrantFiled: March 6, 2020Date of Patent: September 7, 2021Assignee: NOVARTIS AGInventors: Andrew Bryant, Heinrich Buettgen, Wolfgang Papst, Marie Picci
-
Patent number: 11103644Abstract: The invention provides a syringe for use in an ophthalmic injection. The syringe comprises a body, a stopper and a plunger. The body comprises an outlet at an outlet end and the stopper is arranged within the body such that a front surface of the stopper and the body define a variable volume chamber from which a fluid can be expelled though the outlet. The plunger comprises a plunger contact surface at a first end and a rod extends between the plunger contact surface and a rear portion. The plunger contact surface is arranged to contact the stopper but not couple thereto, such that the plunger can be used to force the stopper towards the outlet end of the body, reducing the volume of the variable volume chamber, but not to move the stopper away from the outlet end.Type: GrantFiled: May 10, 2019Date of Patent: August 31, 2021Assignee: NOVARTIS AGInventors: Andrew Bryant, Heinrich Buettgen, Wolfgang Papst, Marie Picci
-
Patent number: 11103420Abstract: A medical device (100) comprises a container receiver unit (110) configured to receive and hold a container (120), wherein the container (120) accommodates a pharmaceutical product (125) and comprises a first communication tag (130) configured to store information regarding the pharmaceutical product (125), a reader unit (140) configured to wirelessly read the information from the first communication tag (130), and a control unit (150) configured to control the medical device (100) based on the information read from the first communication tag (130). The medical device (100) further comprises an opening or a transparent window (165) allowing to at least partially see from the outside the container (120) inserted into the container receiver unit (110), wherein the reader unit (140) comprises a first antenna unit (142, 144), and the container (120) inserted into the container receiver unit (110) is located between (i) the opening or the transparent window (165) and (ii) the first antenna unit (142, 144).Type: GrantFiled: February 5, 2018Date of Patent: August 31, 2021Assignee: NOVARTIS AGInventors: Alain Schmidlin, Mario Iobbi, Erich Studer, Andrew Bryant, Chinmay Deodhar, Rajan Patel, Samuel Coendet, Vivek Gajera, Prakash Parmar
-
Publication number: 20210196890Abstract: The invention relates to an automatic drug delivery device (10), in particular automatic drug delivery device, for dispensing a fluid product, in particular a fluid medicament, including: a longitudinal housing (104) extending along a longitudinal axis and having a proximal end close to the dispensing site, a distal end opposite to the proximal end and a hollow interior; a removable cap (50) mountable to the proximal end of the housing (104); a syringe assembly (200) arranged a mounting position inside the housing (104) and having a hollow syringe body (204) and an injection needle (206) coupled to the hollow syringe body (204) including the fluid product; a drive mechanism (300) which can be triggered by a trigger element in order to initiate the dispensing of the fluid product; wherein the loaded drive mechanism is operatively coupled with a safety shield (102) movable within the longitudinal housing (104), wherein the safety shield (102) is biased into a proximal position in which it protrudes out of the pType: ApplicationFiled: May 23, 2019Publication date: July 1, 2021Inventors: Jacques Appy, Andrew Bryant, Neil Cammish, Congyi Huang, John Palmer-Felgate, Claudio Rossi, Oliver Shergold, Gianluca Tordi, Adrian Francios Von Muralt, Mark Horlock
-
Publication number: 20210196894Abstract: The invention relates to an automatic drug delivery device (10), in particular automatic dmg delivery device, for dispensing a fluid product, in particular a fluid medicament, including: a longitudinal housing (104) extending along a longitudinal axis and having a proximal end close to the dispensing site, a distal end opposite to the proximal end and a hollow interior; a removable cap (50) mountable to the proximal end of the housing (104); a syringe assembly (200) arranged a mounting position inside the housing (104) and having a hollow syringe body (204) and an injection needle (206) coupled to the hollow syringe body (204) including the fluid product; a drive mechanism (300) which can be triggered by a trigger element in order to initiate the dispensing of the fluid product; wherein the loaded drive mechanism is operatively coupled with a safety shield (102) movable within the longitudinal housing (104), wherein the safety shield (102) is biased into a proximal position in which it protrudes out of the prType: ApplicationFiled: May 23, 2019Publication date: July 1, 2021Inventors: Jacques Appy, Andrew Bryant, Neil Cammish, Congyi Huang, John Palmer-Felgate, Claudio Rossi, Oliver Shergold, Gianluca Tordi, Adrian Francios Von Muralt, Mark Horlock
-
Publication number: 20210196900Abstract: The invention relates to an automatic drug delivery device (10), in particular automatic drug delivery device, for dispensing a fluid product, in particular a fluid medicament, including: a longitudinal housing (104) extending along a longitudinal axis and having a proximal end close to the dispensing site, a distal end opposite to the proximal end and a hollow interior; a removable cap (50) mountable to the proximal end of the housing (104); a syringe assembly (200) arranged a mounting position inside the housing (104) and having a hollow syringe body (204) and an injection needle (206) coupled to the hollow syringe body (204) including the fluid product; a drive mechanism (300) which can be triggered by a trigger element in order to initiate the dispensing of the fluid product; wherein the loaded drive mechanism is operatively coupled with a safety shield (102) movable within the longitudinal housing (104), wherein the safety shield (102) is biased into a proximal position in which it protrudes out of the pType: ApplicationFiled: May 23, 2019Publication date: July 1, 2021Inventors: Jacques Appy, Andrew Bryant, Neil Cammish, Congyi Huang, John Palmer-Felgate, Claudio Rossi, Oliver Shergold, Gianluca Tordi, Adrian Francios Von Muralt, Mark Horlock
-
Publication number: 20210196893Abstract: The invention relates to an automatic drug delivery device (10), in particular automatic drug delivery device, for dispensing a fluid product, in particular a fluid medicament, including: •a longitudinal housing (104) •a removable cap (50) •a syringe assembly (200) •a drive mechanism (300) •wherein the loaded drive mechanism is operatively coupled with a safety shield (102) movable within the longitudinal housing (104), •wherein the safety shield (102) is biased into a proximal position in which it protrudes out of the proximal end of the longitudinal housing (104) in order to cover a needle tip (348) of the injection needle (206), and wherein the safety shield (104) is movable into a distal position in which the injection needle (206) is exposed for injection; •wherein the longitudinal housing provides an inner receiving component fixed thereto for receiving a syringe holder and providing a predetermined radial and axial position of the syringe holder within the longitudinal housing; •wherein the syringe assType: ApplicationFiled: May 23, 2019Publication date: July 1, 2021Inventors: Jacques Appy, Andrew Bryant, Neil Cammish, Congyi Huang, John Palmer-Felgate, Claudio Rossi, Oliver Shergold, Gianluca Tordi, Adrian Francios Von Muralt, Mark Horlock
-
Publication number: 20210161706Abstract: The invention provides a syringe for use in an ophthalmic injection. The syringe comprises a body, a stopper and a plunger. The body comprises an outlet at an outlet end and the stopper is arranged within the body such that a front surface of the stopper and the body define a variable volume chamber from which a fluid can be expelled though the outlet. The plunger comprises a plunger contact surface at a first end and a rod extends between the plunger contact surface and a rear portion. The plunger contact surface is arranged to contact the stopper but not couple thereto, such that the plunger can be used to force the stopper towards the outlet end of the body, reducing the volume of the variable volume chamber, but not to move the stopper away from the outlet end.Type: ApplicationFiled: February 12, 2021Publication date: June 3, 2021Inventors: Andrew BRYANT, Heinrich BUETTGEN, Wolfgang PAPST, Marie PICCI
-
Patent number: 10923222Abstract: The present disclosure relates to a system (100) for administering a pharmaceutical product. The system comprises a container (102) accommodating a pharmaceutical product. The container (102) comprises a wireless communication unit (112) and a memory (116) which stores an administration scheme specifically adapted to the pharmaceutical product accommodated in the container (102). The administration scheme specifies at least one administration-related parameter to be adhered to in administering the pharmaceutical product to a patient. The system further comprises a wireless communication device (104; 206; 208) configured to read the administration scheme from the memory (116) of the container (102) and to perform at least one action based on the administration scheme.Type: GrantFiled: February 1, 2018Date of Patent: February 16, 2021Assignee: NOVARTIS AGInventors: Alain Schmidlin, Mario Iobbi, Erich Studer, Andrew Bryant
-
Publication number: 20200372318Abstract: A container arrangement (100) is disclosed, which is preferably destined for pharmaceutical products. The container arrangement includes a container body (110) and a first wireless communication systems (210) composed of a NFC system (210) including an NFC antenna (141). The container arrangement further includes a first and/or a second sensing-switching arrangement (143; 280) configured to include a preset status inhibiting a standardized operability of the first wireless communication system (210). The first sensing-switching arrangement (143) is configured to deregulate its preset status upon an initial opening event and the second sensing-switching arrangement (280) is configured to deregulate its preset status upon an unloading event.Type: ApplicationFiled: March 13, 2017Publication date: November 26, 2020Inventor: Andrew Bryant
-
Publication number: 20200214888Abstract: The invention provides a syringe for use in an ophthalmic injection. The syringe comprises a body, a stopper and a plunger. The body comprises an outlet at an outlet end and the stopper is arranged within the body such that a front surface of the stopper and the body define a variable volume chamber from which a fluid can be expelled though the outlet. The plunger comprises a plunger contact surface at a first end and a rod extends between the plunger contact surface and a rear portion. The plunger contact surface is arranged to contact the stopper but not couple thereto, such that the plunger can be used to force the stopper towards the outlet end of the body, reducing the volume of the variable volume chamber, but not to move the stopper away from the outlet end.Type: ApplicationFiled: March 6, 2020Publication date: July 9, 2020Inventors: Andrew BRYANT, Heinrich BUETTGEN, Wolfgang PAPST, Marie PICCI
-
Publication number: 20200179167Abstract: The invention provides a syringe for use in an ophthalmic injection. The syringe comprises a body, a stopper and a plunger. The body comprises an outlet at an outlet end and the stopper is arranged within the body such that a front surface of the stopper and the body define a variable volume chamber from which a fluid can be expelled though the outlet. The plunger comprises a plunger contact surface at a first end and a rod extends between the plunger contact surface and a rear portion. The plunger contact surface is arranged to contact the stopper but not couple thereto, such that the plunger can be used to force the stopper towards the outlet end of the body, reducing the volume of the variable volume chamber, but not to move the stopper away from the outlet end.Type: ApplicationFiled: February 14, 2020Publication date: June 11, 2020Inventors: Andrew BRYANT, Heinrich BUETTGEN, Wolfgang PAPST, Marie PICCI
-
Publication number: 20200121848Abstract: The invention concerns an injector device (100), comprising access means (110, 115) configured to selectively allow and prevent a cartridge (120) storing a pharmaceutical product (122) from being removed from the injector device (100), a self-test unit (130) configured to cause a self-test of at least one of an electronic component and an electronic assembly of the injector device (100), and a control unit (140) configured to control the access means (110, 115) to allow the cartridge (120) to be removed from the injector device (100) in case the self-test has failed.Type: ApplicationFiled: February 1, 2018Publication date: April 23, 2020Inventors: Alain Schmidlin, Mario Iobbi, Erich Studer, Andrew Bryant, Chinmay Deodhar, Rajan Patel